Nonhuman primate models for Epstein-Barr virus infection

Current Opinion in Virology

Volumn 3, Issue 3, 2013, Pages 233-237

  Wang, Fred ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; EPSTEIN BARR VIRUS ANTIGEN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; B CELL LYMPHOMA; CELLULAR IMMUNITY; DNA SEQUENCE; EPSTEIN BARR VIRUS INFECTION; GENETIC ORGANIZATION; HUMORAL IMMUNITY; IMMUNE EVASION; IN VITRO STUDY; INFECTION; INNATE IMMUNITY; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; RHESUS MONKEY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS ENTRY; VIRUS GENE; VIRUS SHEDDING;

EID: 84880299051     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2013.03.003     Document Type: Review

References (22)

1. S.D. Ma, S. Hegde, K.H. Young, R. Sullivan, D. Rajesh, Y. Zhou, E. Jankowska-Gan, W.J. Burlingham, X. Sun, and M.L. Gulley A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas J Virol 85 2011 165 177
2. G. Miller, T. Shope, D. Coope, L. Waters, J. Pagano, G. Bornkamn, and W. Henle Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses J Exp Med 145 1977 948 967
3. M.A. Epstein, A.J. Morgan, S. Finerty, B.J. Randle, and J.K. Kirkwood Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine Nature 318 1985 287 289
4. J.C. Ramer, R.L. Garber, K.E. Steele, J.F. Boyson, C. O'Rourke, and J.A. Thomson Fatal lymphoproliferative disease associated with a novel gammaherpesvirus in a captive population of common marmosets Comp Med 50 2000 59 68
5. Y. Cho, J. Ramer, P. Rivailler, C. Quink, R.L. Garber, D.R. Beier, and F. Wang An Epstein-Barr-related herpesvirus from marmoset lymphomas Proc Natl Acad Sci U S A 98 2001 1224 1229
6. P. Rivailler, Y.G. Cho, and F. Wang Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses J Virol 76 2002 12055 12068
7. M.H. Fogg, A. Carville, J. Cameron, C. Quink, and F. Wang Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate J Virol 79 2005 10069 10072
8. B. Ehlers, A. Ochs, F. Leendertz, M. Goltz, C. Boesch, and K. Matz-Rensing Novel simian homologues of Epstein-Barr virus J Virol 77 2003 10695 10699
9. S.R. Rangan, L.N. Martin, B.E. Bozelka, N. Wang, and B.J. Gormus Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma Int J Cancer 38 1986 425 432
10. P. Rivailler, H. Jiang, Y.G. Cho, C. Quink, and F. Wang Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model J Virol 76 2002 421 426
11. M. Franken, O. Devergne, M. Rosenzweig, B. Annis, E. Kieff, and F. Wang Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1 J Virol 70 1996 7819 7826
12. M. Franken, B. Annis, A.N. Ali, and F. Wang 5′ coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio J Virol 69 1995 8011 8019
13. R. Peng, A.V. Gordadze, E.M. Fuentes Panana, F. Wang, J. Zong, G.S. Hayward, J. Tan, and P.D. Ling Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses J Virol 74 2000 379 389
14. N.W. Blake, A. Moghaddam, P. Rao, A. Kaur, R. Glickman, Y.G. Cho, A. Marchini, T. Haigh, R.P. Johnson, and A.B. Rickinson Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1 J Virol 73 1999 7381 7389
15. A. Moghaddam, J. Koch, B. Annis, and F. Wang Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus J Virol 72 1998 3205 3212
16. K. Mansfield Development of specific pathogen free non-human primate colonies S. Wolfe-Coote, The Laboratory Primate 2005 Elsevier Academic Press 230 239
17. A. Moghaddam, M. Rosenzweig, D. Lee-Parritz, B. Annis, R.P. Johnson, and F. Wang An animal model for acute and persistent Epstein-Barr virus infection Science 276 1997 2030 2033
18. P. Rivailler, A. Carville, A. Kaur, P. Rao, C. Quink, J.L. Kutok, S. Westmoreland, S. Klumpp, M. Simon, and J.C. Aster Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host Blood 104 2004 1482 1489
19. M. Ohashi, N. Orlova, C. Quink, and F. Wang Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene J Virol 85 2011 1330 1339
20. M. Ohashi, M.H. Fogg, N. Orlova, C. Quink, and F. Wang An Epstein-Barr virus encoded inhibitor of colony stimulating factor-1 signaling is an important determinant for acute and persistent EBV infection PLoS Pathog 8 2012 e1003095
21. E.M. Sokal, K. Hoppenbrouwers, C. Vandermeulen, M. Moutschen, P. Leonard, A. Moreels, M. Haumont, A. Bollen, F. Smets, and M. Denis Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults J Infect Dis 196 2007 1749 1753
22. J. Sashihara, Y. Hoshino, J.J. Bowman, T. Krogmann, P.D. Burbelo, V.M. Coffield, K. Kamrud, and J.I. Cohen Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge PLoS Pathog 7 2011 e1002308